Kidney Cancer (Canada) Top 10
- What are the treatment options for patients with advanced non-clear cell renal cell carcinoma (kidney cancer)?
- Are there measurable, biological indicators (biomarkers) that can be used to predict the response to a treatment?
- Are there measurable, biological indicators (biomarkers) for the detection of kidney cancer?
- Can we develop better therapies that use the immune system to fight cancer (immunotherapies) including biomarkers, immune markers of patient, tumour characteristics and response?
- What indicators can be used to predict the development and progression of metastatic kidney cancer?
- How can psychological, emotional and social support be best given to patients and their families?
- Can decision making tools be developed that help both patients and healthcare providers to make treatment decisions in advanced/metastatic disease?
- What is the role and criteria for using biopsy in the management of kidney cancer?
- Does our government funding structure reflect outcomes of our kidney cancer patients compared to the rest of the world?
- What causes kidney cancer (including risk factors and dietary causes)?